Biotechnology & Life Sciences Global On demand · 24-48h

Global Biological Sample Temperature-controlled Storage Services Market Strategic Research Report

Global Biological Sample Temperature-controlled Storage Serv…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biological Sample Temperature-controlled Storage Services Market
$6642025
10.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Cells and Cell Lines, Tissues and Organs, Nucleic Acids, Proteins and Biologics, Others

By Application: Pharmaceutical and Biotechnology Companies, Research Institutions and Universities, Hospitals and Clinical Diagnostic Facilities, Government, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, IQVIA, Labcorp, Eurofins, Merck, Quest Diagnostics, ICON, Charles River Laboratories, EPL Archives (VWR), Precision for Medicine, Azenta, Versiti, Cryoport, Alcami, HKSTP, BioLife Solutions, Kryosphere, BioArkive, Tescor, Precision Stability Storage, Birka BioStorag, Vigilant Bioservices, Medpace, WuXi AppTec, Goodwill E-health Info, Shanghai Outdo Biotech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 162 pages
Market size 2025
$664
Million USD
Forecast CAGR
10.9%
2025-2032
Forecast 2032
$1369.9
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Biological Sample Temperature-controlled Storage Services market size is predicted to grow from US$ 664 million in 2025 to US$ 1,349 million in 2032; it is expected to grow at a CAGR of 10.9% from 2026 to 2032.

Biological Sample Temperature-controlled Storage Services refer to specialized third party services that store biological samples under precisely controlled and continuously monitored temperature conditions to preserve sample stability, viability, and integrity for research, clinical, diagnostic, or biomanufacturing purposes. The service typically covers defined temperature bands ranging from refrigerated through frozen, ultra-low, and cryogenic storage, supported by validated equipment, alarmed monitoring, backup power and redundancy, secure access control, documented quality procedures, inventory and chain of custody tracking, and standardized processes for sample receipt, labeling, retrieval, and temperature-controlled dispatch.

The biological sample temperature controlled storage services market is moving from a capacity driven business toward a risk management and compliance driven business, as sponsors and laboratories place greater value on proven chain of custody, audit readiness, and continuity planning than on storage space alone. The differentiation is increasingly created through multi temperature networks, validated processes, and integrated sample operations such as accessioning, inventory governance, and rapid retrieval that shorten study timelines and reduce the probability of sample loss or temperature excursions. Demand is also being reinforced by the growth of complex clinical studies and distributed research models that require reliable regional depots and standardized handling across sites. As a result, providers with strong quality systems, redundant infrastructure, and digital visibility tools are best positioned to capture share, while smaller single site operators face rising customer expectations around documentation, resilience, and global scalability.

This report presents a comprehensive overview of the global Biological Sample Temperature-controlled Storage Services market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Material Type

  • Cells and Cell Lines
  • Tissues and Organs
  • Nucleic Acids
  • Proteins and Biologics
  • Others

Segment by Storage Temperature

  • Room Temperature Storage
  • Low Temperature Storage
  • Ultra-low Temperature Storage
  • Liquid Nitrogen Storage
  • Others

Segment by Service Scope

  • On-site Managed Service
  • Off-site Commercial Repository

Segment by Application

  • Pharmaceutical and Biotechnology Companies
  • Research Institutions and Universities
  • Hospitals and Clinical Diagnostic Facilities
  • Government
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biological Sample Temperature-controlled Storage Services market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical and Biotechnology Companies, Research Institutions and Universities, Hospitals and Clinical Diagnostic Facilities evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biological Sample Temperature-controlled Storage Services Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 10.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$664
2025
Forecast
$1369.9
2032
CAGR
10.9%
2025–2032
Regions
5
global
Key companies
Thermo Fisher ScientificIQVIALabcorpEurofinsMerckQuest DiagnosticsICONCharles River Laboratories
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Cells and Cell LinesTissues and OrgansNucleic AcidsProteins and BiologicsOthers
By Application
Pharmaceutical and Biotechnology CompaniesResearch Institutions and UniversitiesHospitals and Clinical Diagnostic FacilitiesGovernmentOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Cells and Cell Lines
  • 3.1.3 Tissues and Organs
  • 3.1.4 Nucleic Acids
  • 3.1.5 Proteins and Biologics
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical and Biotechnology Companies
  • 4.1.3 Research Institutions and Universities
  • 4.1.4 Hospitals and Clinical Diagnostic Facilities
  • 4.1.5 Government
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IQVIA
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Labcorp
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Eurofins
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Merck
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Quest Diagnostics
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 ICON
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Charles River Laboratories
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 EPL Archives (VWR)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Precision for Medicine
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Azenta
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Versiti
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Cryoport
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Alcami
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 HKSTP
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 BioLife Solutions
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Kryosphere
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 BioArkive
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Tescor
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Precision Stability Storage
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Birka BioStorag
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Vigilant Bioservices
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Medpace
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 WuXi AppTec
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Goodwill E-health Info
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Shanghai Outdo Biotech
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Biological Sample Temperature-controlled Storage Services market?
The global Biological Sample Temperature-controlled Storage Services market is estimated at US$ 664 million in 2025 (base year) and is projected to reach US$ 1.35 billion by 2032.
How fast is the Biological Sample Temperature-controlled Storage Services market expected to grow?
The market is expected to grow at a CAGR of 10.9% from 2026 to 2032, expanding from US$ 664 million in 2025 to US$ 1.35 billion in 2032, roughly 2.0 times its base-year value.
What does the Biological Sample Temperature-controlled Storage Services market cover?
Biological Sample Temperature-controlled Storage Services refer to specialized third party services that store biological samples under precisely controlled and continuously monitored temperature conditions to preserve sample stability, viability, and integrity for research, clinical, diagnostic, or biomanufacturing purposes.
How is the Biological Sample Temperature-controlled Storage Services market segmented by material type?
By material type, the market is segmented into Cells and Cell Lines, Tissues and Organs, Nucleic Acids, Proteins and Biologics and Others.
What are the key applications of Biological Sample Temperature-controlled Storage Services?
Key applications covered include Pharmaceutical and Biotechnology Companies, Research Institutions and Universities, Hospitals and Clinical Diagnostic Facilities, Government and Others.
Which companies are profiled in the Biological Sample Temperature-controlled Storage Services market report?
Key players profiled include Thermo Fisher Scientific, IQVIA, Labcorp, Eurofins, Merck, Quest Diagnostics, ICON and Charles River Laboratories, among 26 companies covered in total.
What geographies does the Biological Sample Temperature-controlled Storage Services market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Biological Sample Temperature-controlled Storage Services?
The biological sample temperature controlled storage services market is moving from a capacity driven business toward a risk management and compliance driven business, as sponsors and laboratories place greater value on proven chain of custody, audit readiness, and continuity planning than on storage space alone.
Who should buy the Biological Sample Temperature-controlled Storage Services market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical and Biotechnology Companies, Research Institutions and Universities and Hospitals and Clinical Diagnostic Facilities, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biological Sample Temperature-controlled Storage Services market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.